墨西哥急性曲张静脉出血处理与治疗共识
该共识由17名墨西哥国内专家和3名国际专家组成5个工作组,采用RAND/UCLA流程及改良Delphi法,针对肝硬化门静脉高压急性曲张静脉出血(AVB)的5个主题领域制定推荐:初始评估、液体复苏与初始药物治疗、内镜作用、止血失败处理策略、二级预防。共产生28条声明,对初始液体复苏和输血策略给出具体推荐,强调血管加压药物使用、内镜作用及AVB预防的重要性。共识旨在标准化墨西哥不同医疗层级的AVB诊疗流程、改善临床决策并降低6周死亡率(原文述AVB 6周死亡率高达15%–25%)。
要点
- 门静脉高压是肝硬化主要后果,约50%肝硬化患者存在胃食管静脉曲张,AVB为内科急症,6周死亡率达15%–25%。
- 共识共产生28条声明,对初始液体复苏和输血策略给出具体推荐。
- 共识强调血管加压药物在AVB处理中的使用重要性。
- 共识强调内镜在AVB诊疗中的作用及AVB预防的重要性。
- 共识覆盖从初始评估到二级预防的全流程,旨在标准化墨西哥不同医疗层级的AVB管理。
适用人群与场景
- 门静脉高压合并急性曲张静脉出血的肝硬化患者。
- 目标为墨西哥不同医疗层级中的AVB诊疗。
处置流程与药物剂量
- 共识涵盖5个主题:初始评估、液体复苏与初始药物治疗、内镜作用、止血失败处理策略、二级预防。
- 共识对初始液体复苏和输血策略给出具体推荐。
- 共识强调血管加压药物的使用。
- 共识强调内镜在AVB诊疗中的作用。
- 共识给出AVB二级预防推荐。
研究设计与关键结果
- 共识由17名墨西哥国内专家和3名国际专家组成5个工作组制定。
- 共识采用RAND/UCLA流程及改良Delphi法。
- 共产生28条声明,涵盖初始液体复苏与输血策略、血管加压药物使用、内镜作用及AVB预防。
- 原文述AVB 6周死亡率高达15%–25%。
证据类型、等级与局限
- 证据类型:专家共识(墨西哥首个急性曲张静脉出血共识)。
- 制定方法:RAND/UCLA流程,改良Delphi法。
- 证据基础:基于最佳可用证据和墨西哥胃肠病学专家意见。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该共识为墨西哥不同医疗层级提供AVB标准化管理框架,覆盖从初始评估到二级预防的全流程。
- 共识强调初始液体复苏和输血策略需遵循具体推荐。
- 共识强调血管加压药物在AVB处理中的使用。
- 共识强调内镜在AVB诊疗中的作用及AVB预防的重要性。
指南或共识出处
- 墨西哥急性曲张静脉出血共识(Mexican consensus on the approach to and treatment of acute variceal bleeding),发表于Revista de Gastroenterología de México(英文版)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION AND AIMS: Portal hypertension is the main consequence of cirrhosis and the cause of most of its complications, such as ascites, variceal bleeding, and hepatic encephalopathy. The development of those complications marks the transition from compensated cirrhosis to decompensated cirrhosis, and the latter is associated with poor prognosis. Approximately 50% of cirrhotic patients have gastroesophageal varices. Acute variceal bleeding (AVB) is a medical emergency with high mortality rates ranging from 15 to 25% within 6 weeks. AVB management has evolved in recent years due to new evidence on fluid resuscitation and transfusion support, advances in endoscopic techniques, esophageal stent use, and transjugular intrahepatic portosystemic shunt (TIPS) placement. This consensus aimed to establish recommendations based on the best available evidence and expert opinion from Mexican specialists in gastroenterology for the diagnosis, management, and treatment of AVB in patients with portal hypertension. The goal was to improve clinical decision-making, reduce the associated mortality, and standardize care protocols across the different levels of medical care in Mexico.
MATERIAL AND METHODS: Seventeen national and 3 international experts were divided into five working groups to address five thematic areas: 1) initial evaluation, 2) fluid resuscitation and initial pharmacologic therapy, 3) the role of endoscopy, 4) strategies for managing failed bleeding control, and 5) secondary prophylaxis recommendations. The consensus was developed utilizing the RAND/UCLA process, with a modified Delphi method.
RESULTS: A total of 28 statements were produced, with specific recommendations on initial fluid resuscitation and transfusion strategy, and highlighting the importance of vasopressor use, the role of endoscopy, and AVB prophylaxis.
CONCLUSIONS: This first Mexican Consensus on Acute Variceal Bleeding establishes practical recommendations for standardizing AVB management in patients with cirrhosis in Mexico, from the initial evaluation to secondary prophylaxis, emphasizing the importance of specific strategies and laying the groundwork for future research.
参考来源
- Higuera-de-la-Tijera F, Noble-Lugo A, Crespo J, et al. Mexican consensus on the approach to and treatment of acute variceal bleeding. Rev Gastroenterol Mex (Engl Ed). 2025. PMID: 40957796. doi:10.1016/j.rgmxen.2025.09.007
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。